3.1 GESTIÓN DE IDENTIDADES
3.1.1 DIRECTORIO DE IDENTIDADES DE LA ECIBCE
Adson M A, Van Heerden J A (1980). Major hepatic resection for metastatic colorectal cancer. Ann Surg; 191: 576-583.
Allcock G H & Warner T D (1995). Inhibition o f ETB receptors limits efficacy of
non selective Endothelin antagonist in vivo.
J Cardiovasc Pharmacol; 26 Suppl 3: S I77-9
Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Nakajima N (1999). Adjuvant regional chemotherapy after hepatic resection for colorectal métastasés.
B rJ S u rg ; 86 (8): 1025-1031.
Amin Z, Donald J J, Masters A, Kent R, Steger A, Bown S, Lees W (1993a) Hepatic métastasés: interstitial laser photocoagulation with real time ultrasound monitoring and dynamic CT evaluation of treatment. Radilolgy; 187(2): 339-347
Amin Z, Bown SO, Less WR (1993b). Local treatment for colorectal liver métastasés: a comparison o f interstitial laser photocoagulation and precutaneous alcohol injection.
Clin Radiol; 48: 166-171.
Anderson SA (1991). Growth Factors & Cancer. Science, 254/5035: 1146-1153.
Aral H, Hari S, Arimori I, Ohkubo H, Nakanishi S (1990). Cloning and expression of
cDNA encoding an endothelin receptor. Nature ; 348: 370-372.
Arai H, Nakao K, Takaya K, Hosoda K, Ogawa Y, Nakanishi S, Imuro H (1993).
The human Endothelin-B receptor gene. Structural organization and chromosomal assignment J Biol Chem; 268(5):3463-70.
Arbuck SG (1989). Overview o f clinical trials using 5-fluorouracil and Leucovorin for the treatment o f colorectal cancer. Cancer; 63: 1036-1044.
Archer SG, Gray BN (1989). Vascularization o f small liver métastasés. Br. J. Surg; (76): 545-548.
Ashraf S, Loizidou M, Crowe R, Turmaine M, Taylor I, Bumstock G (1997). Blood vessels in liver métastasés from both sarcoma and carcinoma lack perivascular
innervation and smooth muscle cells. Clin Exp Metastasis'^ 15: 484-498.
Bagnato A, Tecce R, Di Castro V, Cott K (1997). Activation of mitogenic signaling by Endothelin-1 in ovarian carcinoma cells. Can Res; 57: 1306-1311.
Bagnato A, Salani D, Di Castro V, Wu-Wong J, Tecce K, Nicotra M, Venuti A, Natali P (1999). Expression o f Endothelin-1 and Endothelin-A receptor in ovarian carcinoma: Evidence for an autocrine role in tumour growth. Can Res ; 59: 720-727.
Barba D, Hardin J, Sadelain M, Gage F (1994). Development o f antitumor immunity following thymidine kinase mediated killing o f experimental brain tumours.
Proc Natl Acad Sci ; 172: 1217-1224.
Batistini B, Chailler P, D ’Orleans-Justie P, Briere N (1993). Growth regulatory properties o f endothelins. Peptides^ 14: 385-399.
Bauer M, Zhang J, Bauer I, Clemens M (1994). ET-1 induced alteration o f hepatic microcirculation sinusoidal and extra sinosoidal sites o f action.
Am J Physiol', 267: (GI, liver physiol. 30): G143-G149.
Bengmark S & Jeppsson B (1989). Status o f iscloemic therapy for hepatic tumours.
Surg Clin N A m ; 69: 411-418.
Berridge M (1986). Growth factors, oncogenes and inositol lipids.
Berridge M, Irvine R F (1989). Inositol phosphates and cell signaling.
Nature (London) ; 341: 197-205.
Betsholtz C, Heldin CH, Nister M, Wasteson A, Westmark B (1983). Synthesis of a PDGF-like growth factor in human glioma and sarcoma cells suggests the expression
o f the cellular homologue to the transforming protein o f simian sarcoma virus.
Biochem Biophys Res Commun ; 117: 170-182.
Binet 1, Wallnofer A, Weber C, Jones R, Theil G (2000). Renal haemodynamics and
pharmacokinetics of bosentan with and without cyclosporin.
Kidney Inf, 57 (1):224-31.
Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castairey D (1996). Resection o f non resectable liver métastasés from colorec cancer after neoadjuvant
chemotherapy o f Surgery', 224 (4): 509-522.
Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S (1990). Growth factor activity o f Endothelin on vascular smooth muscle, J Physiol ; 258: C 408-415.
Bogoyevitch M, Parker P, Sudgen P (1993). Characterization o f proteinkinase C isotype expression in adult rat heart. Circ Res ; 72: 757-767.
Bos J L (1989). ras Oncogenes in Human Cancer: A review.
Can Res ; 49: 4682-4689.
Bowen-Pope DF, Vogel A, Ross R (1984). Production o f platelet derived growth
factor like molecules and reduced expression o f platelet derived growth factor receptors accompany transformation by a wide spectrum o f agents. Proc Natl Acad
Bown S G (1983). Phototherapy o f tumours. World J Surg; 7:700-707.
Bozetti F, Bignami P, Montalto F, Doci R, Gennari L (1992). Repeated hepatic resection for recurrent métastasés from colorectal cancer. B r J S u r g ; 79:146-148.
Bradley S J, Garfinkle G, Walker E (1986). Increased expression o f the epidermal
growth factor on human carcinoma cells. Arch Surg; 121: 1242-1247.
Breedis C, Young C (1954). The blood supply o f the liver. Am JP a th ;30: 969-974.
Brown K & Littlewood C (1989). Endothelin stimulates DNA synthesis in Swiss 3T3 synergy with polypeptide growth factors. Biochem J \ 263: 977-980.
Bunchman TE, Brookshire CA (1991). Cyclosporine-induced synthesis o f endothelin by cultured human endothelial cells. J Clin Invest ; 88: 310-314.
Businaro R, Butler R H, Rubenstein A E, Revoltella R P (1981). Monocolonal antibodies against mouse nerve growth factor produced by somatic cell hydrids.
JN eurosci Res ; 6(1): 89-98.
Cancer Research Campain (1993). Facts on cancer. Facts sheet 18.1-18.4
Carr I and Orr W (1983). Invasion and métastasés. Can M ed Assoc J; 128(10): 1164-7
Carroll N, Chiocca EA, Takahashi K, Tanabe K (1996). Enhancement o f gene therapy specificity for diffuse colon carcinoma liver métastasés with recombinant Herpes
Simplex virus. Annals o f Surgery ; 224 (3): 323-330.
Carter R, Anderson J, Cooke T, Baxter J, Argerson W (1994). Splanchmic blood flow changes in the presence o f repatic tumours, evidence o f humeral mediator.
Chen L, Rivens I, Haar G, Riddler S, Hill C R, Bensted J P (1993). Histological changes in rat liver tumours treated with high intensity focused ultrasound.
Ultrasound M ed Biok 19(1): 67-74.
Chen S, Chen XU, Wang Y, Kosal K, Finegold M, Rich S (1995). Combination gene therapy for liver métastasés o f colon carcinoma in vivo. Proc Natl Acad Sci USA
;9 2 : 2577-2581.
Cheung AY (1982). Microwave and radiofrequency techniques for clinical
hyperthermia. Br J Cancer ; 45(S): 16-24.
Chua BHL, Krebs CJ, Chua CC, Diglio CA (1992). ET stimulates protein synthesis in SMC. Am J Physiol ; 262: E 412-E 416.
Chua BHL, Krebs CJ, Chua CC, Diglio CA (1992). ET stimulates protein synthesis in smooth muscle cell. Am J Physiol^ 262: E412-E416.
Clouthier D, Hosoda K, Richardson J (1998). Cranial and cardiac neural crest defect in endothelin-A receptor deficient mice. Development ; 125: 813-824.
Clozel M, Fischli W (1989). Human cultured endothelial cells do secrete
QnàoihQ\m-\. J Car diovasc Pharmacol ; 13: S 229-231.
Cody W L, Dorerty A M, He J, DePue P, Rapundolo S, Hingorani G A, Major T,
Panek R L, Dudley D, Haleen S J, La Douceur D, Hill K E, Flynn M, Reynulds E (1992). Designing o f frmctional hexapepticle antagonist o f endothelin.
J M ed Chem ; 35: 3301-3303.
Collet M and Erickson R (1978). Protein kinase activity associated with the avian
Coffey RJ, Goustin AS, Soderquist AM et al. (1987). Transforming growth factor a
and p expression in human cancer lines. Implications for an autocrine model.
Cancer Res; 47:4590-4594.
Culver K W, Vickers T M, Lamsam J L, Walling H W, Seregina T (1995). Gene
therapy for solid tumours. Br M ed Bull; 51(1):226- 234.
Curran T, Bravo R, Muller R (1989). Transient induction o f c-fos and C-myc is an
immediate consequence o f growth factor stimulation. In : Roberts A B and Sprun M B eds. Growth factors and malignancy, cancer survey, vol 4 Oxford: Oxford
University Press pp 655-681.
Darzi A, Goldin R, Guillou P, Monson J (1993). High frequency shock waves pyrotherapy. A new concept in extra corporal tumour therapy.
Surg Oncol ; 2(3): 197-203.
Dashwood MR, Barker S G, Muddle JR, Yacoub M H, Martin J F (1993).
[125 I] -Endothelin-1 binding to vasavasorum and regions o f neo-vascularization in human & procine blood vesseles: A possible role for endothelin in intimai hyperplasia and atherosclerosis. J Cardiovas Pharmacol ; 22(Suppl 8): S343-S347.
De Baere T, Elias D, Ducreux M, Dromain C, Kuach V, El Din MG, Sdbotka A,
Lasser A, Roche A (1999). Percutaneous radiofrequency ablation o f hepatic métastasés. Preliminary Experience. Gastroenterologie clinique et biologique
; 23(11): 1128-1133.
De Jong KP, Stellema R, Karrenbeld A, Koudstad LJ, Gouw AS, Sluiter J, Peters PM, Slooff MJ, De Vries EG (1998). Clinical relevance o f transforming growth factor
alpha: Epidermal growth factor receptor, P 53, and Ki 67 in colorectal liver métastasés and corresponding primary tumours. Hepatology ; 28 (4): 971-979.
Delaloye B, Bischof-Delaloye A, Volant J C (1985). First approach to therapy o f liver
métastasés in colorectal carcinoma by intrahepatically infused 1-131 labelled monocolonal anti-CEA antibodies. Eur J Nuclear Medicine ; 11: A 11
De Matteo RP, Fong Y, Blumgart LH (1999). Surgical treatment o f malignant liver
tumours. Baillieres Best Pract Res Clin Gastroenterol] 13(4): 557-74.
De Mey J, Vanboutte P (1982). Heterogeneous behaviour o f the canine arterial and venous wall: Importance o f endothelium. Circ Res ; 51: 439-447.
Denton G W, Durrant L, Hardcastle J, Austin E, Sewell H F (1994). Clinical outcome of colorectal cancer patients treated with human monocolonal anti-idiotypic antibody.
Br J Cancer] 57: 10-14.
Doolittle R, Hunkapiller M W, Hood L, Devare S G, Robbhs K C, Aaronson S A (1983). Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet derived growth factor. Science ; 221: 275.
Douglas SA, Gellai M, Ezekiel M, Oblstein E (1994). BQ-123, a selective endothelin
subtype A-receptor antagonist, lowers blood pressure in different rats models o f hypertension. J Hypertension ; 12: 561-567.
Douglas S A, Vickery- Clarck L M, Louden C, Elliot J D, Oblestein E H (1995).
Endothelin receptor subtype in the pathogenesis o f angioplasty-induced neointima formation in the rat: a comparison o f selective ETA receptor antagonism and dual ETA/ETB receptor antagonism using BQ-123 and SB 209610. J car diovasc
Pharmacol] 26 Suppl 3:S186-S189.
Douglas SA (1997). Clinical development o f endothelin receptor antagonist.
Economos K, MacDonald P, Casey L (1992). Endothelin-1 gene expression and
biosynthesis in human endometrial HEC-IA cancer cells. Cancer Res; 52: 554-557.
Eguchi S, Hirata Y, Ihara M, Yano M, Marumo FEES (1992). A novel ETA
antagonist (BQ-123) inhibits endothelin-1 induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. ¥EBS Letters; 302: 243-246.
Eguchi S, Hirata Y, Imai T, Marumo F (1995). Endothelin-1 as an autocrine growth factor for Endothelin cells. Jcardiovasc Pharmacol; 26 (Suppl 3): S279-83.
Elias D Lasser P, Hoang J M (1993). Repeat hepatectomy for cancer.
Br J Surg; 80: 1557-62
Elias D, Favace F, Triebel F, Hattchouel J, Pignon J, Le Cerne A, Rougier P, Lasser P, Duvillard P, Escudier B (1995). Phase I-II randomized study on prehepatectomy recombinant interleukin-2 immunotherapy in patients with metastatic carcinoma of the colon and rectum. J Am Coll Surg ; 181: 303-310.
Elshopurbagy N A, Korman D R, Wu H L, Sylvester D, Lee J A, Nuthalaganti P,
Bergsma D J, Kumar C S, Nambi P (1993). Molecular characterization and regulation o f the human Endothelin receptors. J Biol Chem ; 268: 3873 - 9.
Emori T, Hirata Y, marumo F (1990). Specific receptors for Endothelin-3 in cultured
bovine endothelial cells and its cellular mechanism of action. FEBS letters; 263(2): 261-264.
Fearon E R, Vogelstein B (1990). A Genetic Model for Colorectal Tumorigenesis.
Fidler I J (1970). Metastatic quantitative analysis o f distribution and fate o f tumour emboli labelled with l-5-iodo-2- deoxyuridine. J N a t Can Inst; 45: 773-82.
Fidler I J, Killion J J (1989). The biology o f tumour metastasis.
Sem Oncol ; 16: 106-115.
Fidler I J (1990). Critical factors in the biology o f human cancer metastasis: twenty-
eight G H A Cklowers memorial award lecture. Cancer Res; 50(19):6130- 8.
Fidler I J (1990). Cancer Métastasés. Br med Bull; 47(1): 157-177.
Finlay IG, McArdle C S (1986). Occult hepatic métastasés in colorectal carcinoma.
B r J S u rg ; 73: 732-735.
Finaly IG, Meek D, Brunton F, McArdle CS (1988). Growth rate o f hepatic
métastasés in colorectal carcinoma. B r J Surg ; 75: 641-644.
Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E (1989). Presence o f growth stimulating factor in serum following primary tumour removal.
Cancer Res ; 49: 1996-2001.
Fisher E R, Fisher B (1965). Experimental study o f factors influencing development of hepatic métastasés from circulating tumor coWs.Acta Cytol ; 9: 146-149.
Flowerdew ADS, Richards HK, Taylor I (1987). Temporary blood, flow stasis with degradable starch microspheres for liver métastasés in rat model. Gut; 28: 1201-1207.
Folkman J (1985). Tumour angiogenesis.
Advances in Cancer Research ;43: 175-203.
Folkman J (1990). What is the evidence that tumours are angiogenesis dependent?
J Nat Cancer Inst 82: 4-6.
Folkman J (1994). Peptides under study. J N a tl Cancer Inst; 86: 742-743.
Foster J, Lundy J (1981). Liver Métastasés. Current Probl Surg, 28 (3): 157-202.
Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M (1994).
Clearance of circulating endothelin-1 by ET g receptors in rats. Biochem Biophys Res
Commun; 199: 1461-1465.
Fukuura T, Miki C, Inoue T, Matsumoto K, Suzuki H (1998). Serum hepatocyte growth factor as an index o f disease status o f patient with colorectal carcinoma.
Br J Cancer ; 78(4): 454-459.
Furchgott R, Zawadzki J (1980). The obligatory role o f endothelial cells in the relaxation of arterial smooth muscle by acetylcholin. Nature (Lond) ; 288: 373-376.
Furuya S, Naruse S, nakayama T, Nokihari K (1992). Binding o f ^^^kendothelin-l to fat storing cells in rat liver revealed by electron microscopic radioautography.
Anat Embryol; 185: 97-100.
Gage A A (1998). History o f cryosurgery. Semin Surg Oncol; 14(2):99-109.
Galzie Z, Femig D, Smith J, Poston G, Kinsella A (1997). Invasion o f human colorectal carcinoma cells is promoted by endogenous basic fibroblast growth factor.
Br J Cancer ; 71 (3): 390-395.
Giaid A, Hamid Q, Springall D, Yanagisawa M, Shinmi O, Sawamura T, Kimura S, Corrin B, Polak JM (1990). Detection o f Endothelin Imnunoreactivity & MRNA in
Goldberg J A, Thompson J A, Fenner J (1991). Angiotensin II as a potensial method
o f targeting cytotoxic loaded microspheres in patients with colorectal liver métastasés. B r J Can ; 64:114-119.
Gordon W L M, Dawson A A, Bennett B, Innes G, Ermin O, Jones PF (1993).
Outcome in colorectal adenocarcinoma-27 year studies o f population.
B r M e d J \3 0 1 : 707-710.
Gray B N, Anderson J, Burton M A (1992). Regression o f liver métastasés following treatment with yttrium 90 microspheres. Aust N Z J Surg ; 62: 105-110.
Graeber T, Osmanian C, Jacks T (1996). Hypoxia mediated selection o f cells with diminished apoptotic potential in solid tumours. Nature ; 379: 88-91.
Gray B N, Anderson J, Burton M A (1992). Regression o f liver métastasés following treatment with yttrium 90 microspheres. Aust N Z J Surg ; 62: 105-110.
Griffith K D, Sugarbaker P H, Chang A E (1990). Repeat hepatic resection for colorectal métastasés. Surgery', 107(l):101-4.
Hanna N (1985). The role o f natural killer cells in the control o f tumour growth and
metastasis. Biochem Biophys Acta ; 780(3): 213-26.
Haugeberg G, Strohmeyer T, Lierse W, Bocker W (1988). The vascularisation of
liver métastasés, y Rej Clin Oncol ; 114: 415-419.
Haunt T M, Flowerdew A D, Birch S J, Williams J D, Muller M A,Taylor I (1990). Prospective randomised controlled trial o f hepatic arterial embolization or infuaion chemotherapy with 5-Fluorouracil and degradable starch microsheres for colorectal cancer Br J Surg ; 71: 719-782.
Haynes W and Webb D J (1994). Contribution of endogenous generation o f
Endothelin-1 to basal vascular tone. Lancet ; 344 (8926): 852-4.
Hickey K, Rubanyi G, Paul R, Highsmith R (1985). Characterization of a coronary
vasoconstrictor produced by cultured endothelial cells.
Am J Physiol ; 248: C550-C556.
Hilgard P (1983). Anticoagulants and tumour growth:pharmacological consideration.
Symp Fundam Can Res ; 36: 353-60.
Hind R E, Loizidou M, Perring S, leming I, Batty V, Birch S, Taylor I (1992). Biodistribution o f lipidol following hepatic arterial injection. Br J Surg ; 79(9): 952-4
Hirata Y, Yoshimi H, Takata S, Watanabe T, Kumagai S, Nakajima K, Sakakibara S (1988). Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells.
Biochem Biophys Res Commun ; 154: 868-875.
Hirata Y, Takagi Y, Fukuda Y, Marumo F (1989). Endothelin is a potent mitogen for rat vasculr smooth muscle cells. Atherosclerosis ; 78: 225-228.
Hofstra R M, Osinga J, Tan-Sindhunata G, Wu Y, Kamsteeg E J, Stulp R, Van Ravenswaaij- Arts C (1996). A homogenous mutation in the Endothelin-3 gene associates with combined Waardenburg type 2 and Hirschsprung phenotype (Shah- Waardenburg syndrome). Nat Genet ; 12(4): 445-7
Hori S, Komatsu Y, Shigemoto R, Mizuno N, Nakanishi S (1992). Distinct tissue distribution and cellular localization o f two messanger ribonucleic acids encoding
Hosada K, Hammer E, Richardson J (1994), Targeted and natural mutations of Endothelin B receptor gene produce megacolon associated with spotted coat colour in mice. Cell ; 79: 1267-1276.
Hughes KS, Simon R, Songharabodi S (1986). Resection o f the liver for colorectal carcinoma metastasis: A multi institutional study o f patterns o f recurrence.
Surgery ; 100: 278-284.
Huscher C, Lirici M, Chiodini S (1998). Laparascopic liver resection.
Semin Laparasc Surg ; 5 (3): 204-210.
Ihara M, Noguchi K, Soeki T, Fukuroda T, Tsuchida S, Kimura S (1992). Biological
profile o f highly potent novel endothelin antagonist selective for ET-A receptors.
Life Soi ; 50: 247-255.
Ikegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S (1990). Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem Biophys Res Commun ; 171: 669-675.
IMPACT (International Multicentre Pooled Analysis o f Colon Cancer Trials) Investigators (1995). Efficacy o f adjuvant fluorouracil and folinic acid in colon cancer. Lancet ; 345: 939-944.
Inganaki H, Bishop A, Escrig C, Wharton J, Allen-Mersh T, Polak J (1991).
Localization o f endothelin like immunoreactivity and endothelin binding sites in human colon. Gastroenterology ; 101: 47-54.
Inganaki H, Bishop A, Imoto T, Polak J (1992). Auto radiographic localization of ET-1 binding sites in human colonic cancer tissue. J Pathology ; 168: 263-267.
Inoue A, Yanagisawa M, Kimura S (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate
genes. Proc Natl Acad Sci USA ; 86: 2863-2867.
Ishibashi M, Fujita M, Nagai K, Ka Ko M, Fume H, Haku E, Osamura Y, Yamaji T
(1993). Production & secretion o f endothelin by hepotocellular carcinoma.
J o f Clin Endocr & Metabolism ; 76: 378-383.
Ishigami SI, Arii S, Fumtani M, Niwano M, Harada T, Mizumoto M (1998). Predictive value o f vascular endothelial growth factor (VEGF) in métastasés and
prognosis o f human colorectal cancer. B r J Cancer ; 78(10): 1379-1384.
Ito H, Hirata Y, Hiroe M, Tsyjino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F (1991). ET-1 induces hypertrophy with enhanced expression o f muscle specific genes in cultured neonatal rat cardiomyocytes. Cire Res ; 69: 209-215.
Jaeck D, Bachellier P, Guiguet M (1997). Long term survival following resection of colorectal hepatic métastasés. B r J Surg ; 84: 977-980.
Jones P A, Del Clerck Y A (1982). Extracellular matrix destmction by invasive
tunour cells. Cancer Metastasis Rev\ 1(4): 289-317.
Kahalah MB (1991). Endothelin: an endothelian dependent vasoconstriction in
scleroderma. Enhanced production and profibrotic action. Arth Rheum ; 34: 978-983.
Kahzuki M, Tanda S, Hori K, Yashida K, Kamimoto M, Wu M, Sato T (1998). Endothelin Receptors and Angiotension receptors in Tumour tissue.
Kainuma O, Asano T, Aoyama H, Takayama W, Nakagohri T, Kenmochi T,
Hasegawa M, Tokoro Y, Sasagawa S, Ochiai T (1999). Combined therapy with radiofrequency thermal ablation and intraarterial infusion chemotherapy for hepatic métastasés from colorectal cancer. Hepatogastroenterology ; 46 (26): 1071-1077.
Kamoi K, Sudo N, Ishibashi M, Yamaji T (1990). Plasma endothelin-1 levels in
patients with pregnancy induced hypertension. N Engl J M ed ; 323: 1486-1487.
Kanno K, Hirata Y, Emori T, Onta K, Schichiri M, Shinohara S (1991). Endothelin
and Raynaud's phenomenon. Am J M ed ; 90: 130-132.
Kasuya Y, Takuwa Y, Yanagisawa N, Kimura S, Goto K, Masaki T(1989).
Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery. Contribution o f phosphoinositide turnover. Biochem Biophys
Res Commun ; 161: 1049-1055.